Clinical Trials
Hyperthyroidism
Thyroid cancer
Archive
Thyroid Cancer
A Phase III Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer. Verified January 2012 by Eisai Inc.
EISAI Protocol (PDF)
Summaries of EUGOGO Studies
Tabella Study B (PDF), Tabella Study C (PDF)
HiLo
A multicentre randomised trial of high versus low dose radioiodine, with or without rhTSH, for remnant ablation following surgery for thyroid cancer. Chief Investigator: Dr Ujjal Mallick and Dr Clive Harmer
HiLo Summary (PDF)